Number (%) | |
---|---|
Years after graduation from medical school, n (%) | |
≤5 years | 20 (5.6) |
6 to 15 years | 137 (38.1) |
16 to 25 years | 112 (31.1) |
≥26 years | 91 (25.3) |
Satisfied with the current research support | 154 (42.8) |
Presentations at academic conferences as a first presenter in the previous year, n (%) | |
None | 42 (11.7) |
1 or 2 presentations | 144 (40.0) |
3 or 4 presentations | 100 (27.8) |
5 to 9 presentations | 65 (18.1) |
≥10 presentations | 9 (2.5) |
Publications in academic journals in the previous year, n (%) | |
None | 99 (27.5) |
1 or 2 publications | 118 (32.8) |
3 or 4 publications | 60 (16.7) |
5 to 9 publications | 50 (13.9) |
≥10 publications | 33 (9.2) |
Experience in clinical research | |
None, n (%) | 68 (18.9) |
Any experience in leading clinical research, n (%) | 292 (81.1) |
Types of clinical research* | |
Case report or case series report, n (%) | 237 (65.8) |
Single-institute retrospective observational study, n (%) | 228 (63.3) |
Single-institute prospective observational study, n (%) | 82 (22.8) |
Multi-institute retrospective observational study, n (%) | 82 (22.8) |
Single-institute interventional study, n (%) | 55 (15.3) |
Multi-institute prospective observational study, n (%) | 53 (14.7) |
Multi-institute interventional study, n (%) | 38 (10.6) |
Systematic review, n (%) | 22 (6.1) |
n (%) | |
---|---|
Statistical analysis | 271 (75.3) |
Research funding | 185 (51.4) |
English editing | 155 (43.1) |
Database creation | 127 (35.3) |
Ethics committee | 106 (29.4) |
Drafting of study protocol | 98 (27.2) |
Literature review | 83 (23.1) |
Identification of clinical questions | 83 (23.1) |
Data collection | 75 (20.8) |
Defining of research questions | 66 (18.3) |
Creation of tables and figures | 36 (10.0) |
Others | 32 (8.9) |
n (%) | |
---|---|
Support for conducting statistical analysis | 193 (53.6) |
Study design consultations | 145 (40.3) |
Support to obtain research grants | 119 (33.1) |
English editing | 107 (29.7) |
Support for statistical analysis planning | 67 (18.6) |
Support for ethics committee application | 57 (15.8) |
Support for study protocol development | 56 (15.6) |
Educational lectures | 50 (13.9) |
Support for data collection | 49 (13.6) |
Support for patient registration | 38 (10.6) |
Support for literature review | 36 (10.0) |
Practical training using educational materials and software | 25 (6.9) |
Support for the development of patient information sheet and informed consent form | 21 (5.8) |
Support for intellectual property and collaborative research | 14 (3.9) |
Support for pharmaceutical affairs | 10 (2.8) |
Others | 21 (5.8) |
≤5 years (n = 20) |
6 to 15 years (n = 137) |
16 to 25 years (n = 112) |
≥26 years (n = 91) |
p | |
---|---|---|---|---|---|
Support for conducting statistical analysis, n (%) | 4 (20.0) | 66 (48.2) | 69 (61.6) | 54 (59.3) | .002 |
Study design consultations, n (%) | 8 (40.0) | 61 (44.5) | 47 (42.0) | 29 (31.9) | .275 |
Support to obtain research grants, n (%) | 3 (15.0) | 43 (31.4) | 39 (34.8) | 34 (37.4) | .256 |
English editing, n (%) | 6 (30.0) | 47 (34.3) | 33 (29.5) | 21 (23.1) | .343 |
Support for statistical analysis planning, n (%) | 5 (25.0) | 23 (16.8) | 21 (18.8) | 18 (19.8) | .762 |
Support for ethics committee application, n (%) | 1 (5.0) | 18 (13.1) | 22 (19.6) | 16 (17.6) | .288 |
Support for study protocol development, n (%) | 4 (20.0) | 13 (9.5) | 19 (17.0) | 20 (22.0) | .050 |
Educational lectures, n (%) | 6 (30.0) | 32 (23.4) | 7 (6.3) | 5 (5.5) | <.001 |
Support for data collection, n (%) | 2 (10.0) | 19 (13.9) | 14 (12.5) | 14 (15.4) | .923 |
Support for patient registration, n (%) | 3 (15.0) | 16 (11.7) | 14 (12.5) | 5 (5.5) | .251 |
Support for literature review, n (%) | 3 (15.0) | 14 (10.2) | 8 (7.1) | 11 (12.1) | .508 |
Practical training using educational materials and software, n (%) | 4 (20.0) | 12 (8.8) | 6 (5.4) | 3 (3.3) | .049 |
Support for the development of patient information sheet and informed consent form, n (%) | 2 (10.0) | 7 (5.1) | 7 (6.3) | 5 (5.5) | .769 |
Support for intellectual property and collaborative research, n (%) | 0 (0) | 5 (3.6) | 4 (3.6) | 5 (5.5) | .817 |
Support for pharmaceutical affairs, n (%) | 0 (0) | 5 (3.6) | 2 (1.8) | 3 (3.3) | .841 |
Ever led clinical trials (n = 79) |
Never led clinical trials (n = 281) |
p | |
---|---|---|---|
Support for conducting statistical analysis, n (%) | 45 (57.0) | 148 (52.7) | .525 |
Study design consultations, n (%) | 23 (29.1) | 122 (43.4) | .027 |
Support to obtain research grants, n (%) | 31 (39.2) | 88 (31.3) | .223 |
English editing, n (%) | 19 (24.1) | 88 (31.3) | .265 |
Support for statistical analysis planning, n (%) | 22 (27.8) | 45 (16.0) | .022 |
Support for ethics committee application, n (%) | 14 (17.7) | 43 (15.3) | .603 |
Support for study protocol development, n (%) | 20 (25.3) | 36 (12.8) | .013 |
Educational lecture, n (%) | 5 (6.3) | 45 (16.0) | .027 |
Support for data collection, n (%) | 11 (13.9) | 38 (13.5) | 1.000 |
Support for patient registration, n (%) | 8 (10.1) | 30 (10.7) | 1.000 |
Support for literature review, n (%) | 1 (1.3) | 35 (12.5) | .002 |
Practical training using educational materials and software, n (%) | 3 (3.8) | 22 (7.8) | .316 |
Support for the development of patient information sheet and informed consent form, n (%) | 5 (6.3) | 16 (5.7) | .789 |
Support for intellectual property and collaborative research, n (%) | 5 (6.3) | 9 (3.2) | .200 |
Support for pharmaceutical affairs, n (%) | 4 (5.1) | 6 (2.1) | .236 |